Site navigation

Navigation

Interstitial laser therapy for breast cancer

 
Guidance issued
 
Number: IPG89

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on interstitial laser therapy for breast cancer.

As part of the NICE's work programme, the current guidance was considered for review but did not meet the review criteria as set out in the IP process guide. The guidance below therefore remains current.

Description

Standard treatments for small breast cancers include lumpectomy or mastectomy (without preceding laser therapy), and minimally invasive techniques such as radiofrequency ablation or cryotherapy.

Interstitial laser therapy is a minimally invasive technique for treating small breast cancers. After locating the tumour using stereotactic techniques or ultrasound, laser energy is delivered into the tumour via a needle probe. This causes the tumour to shrink. A surgeon may then remove the tumour, although sometimes surgery is not necessary.

OPCS code:

Details

Arrangement:
Research Only
Topic area:
Cancer
Specialty:
Clinical oncology
Medical oncology
Specialist advice has been sought from:
British Association of Surgical Oncology
Date notified to NICE:
01 April 2002
Guidance issue date:
22 September 2004

Contact details:

Project manager (for general enquiries or comments)
(for general enquiries or comments)
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links: